The Pharmacy Times® Pharmacy Technician Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to specialty pharmacists.
September 6th 2024
ALZ-801 has now progressed to the phase 3 APOLLOE4 study, designed to evaluate efficacy, safety, and biomarker and imaging effects.
AnaptysBio Announces Strategic Antibody Discovery Partnership with Celgene Corporation
April 12th 2012AnaptysBio, Inc, a privately held therapeutic antibody company, recently announced a strategic partnership with Celgene Corporation to develop novel antibodies against multiple therapeutic targets.
Read More
Novartis Launches the Cancer Cell Line Encyclopedia (CCLE) to Catalogue World's Cancer Cell Lines
March 30th 2012Novartis and the Broad Institute have developed a cancer cell line encyclopedia that catalogues the genetic and molecular profiles of almost 1000 human cancer cell lines used in drug research and development.
Read More
New Legislation Aims to Help West Virginians with Chronic Illnesses
March 26th 2012Cost-sharing practices that limit access to vital medications for West Virginians with serious health conditions may soon be alleviated thanks to a bill just introduced in Congress. The bi-partisan legislation, supported by the American College of Rheumatology, the Arthritis Foundation, and other medical and patient groups, has been introduced by Rep David B. McKinley (R,WV) and Rep Lois Capps (D,CA).
Read More
GlaxoSmithKline announced today that the Oncologic Drugs Advisory Committee (ODAC) to the FDA voted 11 to 2 that evidence from clinical studies support a favorable benefit–risk assessment for use of Votrient in treating patients with advanced soft tissue sarcoma who have received prior chemotherapy.
Read More
Dr. Randell Correia Talks to AJMC TV About Specialty Pharmacy Costs
March 19th 2012Randell "RJ" Correia, PharmD, Senior Vice President, Pharmacy Services, Optum Rx, addresses the rapid rise of specialty pharmacy spending. Dr. Correia discusses the possible complications health reform exchanges may cause and the impact they will have on the future of pharmacy benefit drug management.
Read More
Medco Study Finds Many Patients on Newer Oncology Treatments Are at Risk for Drug Interactions
March 19th 2012New research from Medco Health Solutions Inc shows that many patients using oral cancer medications are also on other drugs that could reduce the effectiveness of the cancer treatment or increase its toxicity.
Read More
Managed Health Care Associates, Inc. (MHA), a leading health care service company focused on alternate site health care providers, announced the completion of its fifth annual Independent Long Term Care Member Study, the results of which were released at the 2012 MHA Business Summit, March 2, 2012 in Las Vegas, Nevada.
Read More
The Infectious Diseases Society of America (IDSA) Proposes New Pathway for Antibiotics
March 12th 2012The Infectious Diseases Society of America (IDSA) proposed a new pathway, the "Special Population Limited Medical Use (SPLMU)" mechanism, to provide an important new approval option for companies interested in developing drugs to treat patients with serious infections where few or no treatment options exist.
Read More
Diplomat Specialty Pharmacy and Ageology Form Strategic Alliance
March 6th 2012Two companies focused on delivering preventative care to individuals looking to fight chronic disease with nutrition, fitness, and bioidentical hormone therapy-Diplomat Specialty Pharmacy and Ageology-announced that they have formed a strategic alliance.
Read More
Independent Specialty Pharmacy Coalition Continues to Urge FTC to Block PBM Merger
March 2nd 2012The Independent Specialty Pharmacy Coalition (ISPC), a national group of community based specialty pharmacies, recently sent a letter to the Federal Trade Commission (FTC), urging the Commission to protect consumers and restrict anticompetitive conduct if it chooses to approve the proposed merger between Express Scripts, Inc (ESI) and Medco Health Solutions.
Read More
Biogen Idec Submits Application to FDA for Approval of Oral BG-12 to Treat Multiple Sclerosis
March 1st 2012Yesterday Biogen Idec announced the company has submitted a New Drug Application (NDA) to the FDA for marketing approval of BG-12 (dimethyl fumarate), the company's oral therapeutic candidate for the treatment of multiple sclerosis (MS).
Read More
Walgreens Specialty Pharmacy Shows Cost Savings Through Alternate Treatment Sites
February 25th 2012New data unveiled at the 17th Annual Pharmacy Benefit Management Institute Conference shows patients, health plans and employer groups can save as much as 60 percent through site-of-care optimization.
Read More
AstraZeneca Launches Direct-to-Patient Program for Arimidex
February 17th 2012AstraZeneca recently announced its first direct-to-patient program offering patients with prescriptions for Arimidex (anastrozole) the opportunity to receive their medication for $40 a month through Express Scripts, a specialty pharmacy provider.
Read More
Manufacturer Considerations for Designing a Distribution Strategy for Specialty Products
February 16th 2012As health care costs continue to increase, and with high-cost specialty products making up a significant portion of the pipeline, the role of the Specialty Pharmacy (SP) continues to grow and influence health care decisions across multiple stakeholders.
Read More
Counterfeit Version of Cancer Drug Avastin Distributed in the United States
February 15th 2012The FDA released a statement on February 14, 2012, warning pharmacies, medical practices, and patients that a counterfeit version of the drug Avastin-an injectable drug used to treat cancer of the colon, lung, kidney, and brain-has been purchased and used by some medical practices in the United States.
Read More